VANGUARD GROUP INC - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,735,786
+35.4%
2,643,195
+0.7%
0.00%
Q2 2023$8,665,895
+5.6%
2,626,029
-8.8%
0.00%
Q1 2023$8,203,699
-46.9%
2,878,491
+35.7%
0.00%
Q4 2022$15,438,135
-2.4%
2,120,623
+8.4%
0.00%
Q3 2022$15,825,000
+111.1%
1,956,092
+27.9%
0.00%
Q2 2022$7,495,000
-78.9%
1,529,662
+1.7%
0.00%
-100.0%
Q1 2022$35,565,000
+36.9%
1,503,821
+2.4%
0.00%0.0%
Q4 2021$25,981,000
-26.5%
1,468,659
+17.2%
0.00%0.0%
Q3 2021$35,359,000
+272.0%
1,253,426
+38.2%
0.00%
Q2 2021$9,505,000
-4.3%
907,035
+7.6%
0.00%
Q1 2021$9,933,000
+28.3%
843,195
+27.5%
0.00%
Q4 2020$7,743,000
+60.9%
661,206
+9.0%
0.00%
Q3 2020$4,811,000
-38.1%
606,552
+42.8%
0.00%
Q2 2020$7,768,000
+461.3%
424,738
+266.4%
0.00%
Q1 2020$1,384,000
+12.7%
115,917
+57.0%
0.00%
Q4 2019$1,228,000
+1058.5%
73,834
+361.5%
0.00%
Q3 2019$106,00015,9970.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$19,415,0007.94%
TRV GP IV, LLC 2,343,154$11,481,0007.55%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 949$193,741,0002.02%
Logos Global Management LP 1,950,000$9,555,0001.75%
COWEN AND COMPANY, LLC 2,385,885$11,691,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,355,624$16,443,0000.62%
ACUTA CAPITAL PARTNERS, LLC 200,000$980,0000.55%
RTW INVESTMENTS, LP 3,961,194$19,410,0000.50%
Parkman Healthcare Partners LLC 262,689$1,287,0000.47%
Deep Track Capital, LP 1,000,000$4,900,0000.32%
View complete list of FULCRUM THERAPEUTICS INC shareholders